Novavax Other Long Term Liabilities (Quarterly) Insights

Novavax, Inc. (NVAX)

8.25 -0.42 (-4.84%) USD | NASDAQ | Jan 14, 15:56

View Other Long Term Liabilities (Quarterly) for NVAX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Pfizer Inc.	Upgrade
Moderna, Inc.	Upgrade
Merck & Co., Inc.	Upgrade
Arcturus Therapeutics Holdings, Inc.	--
Denali Therapeutics, Inc.	--